Valvular Heart Disease
Aortic stenosis and mitral regurgitation are the two most common valvular heart lesions. Many patients with significant valvular heart disease are often not diagnosed or are referred late. Furthermore, there is a large variation in access to valve surgery and percutaneous valve intervention across the country. Health professionals in primary care are generally the first point of contact for people with symptoms of severe valvular heart disease and, thus, are well situated to provide early diagnosis and facilitate referral for specialist management.
The incidence of aortic stenosis and mitral regurgitation increases with age, hence many patients are not suitable for surgery or pose high surgical risk. Transcatheter aortic valve insertion (TAVI) is now considered the first line treatment option for severe aortic stenosis patients with high surgical risk. Percutaneous mitral intervention is also an established therapy for the treatment of mitral regurgitation in the high surgical risk population.
- Conduct the initial evaluation of a cardiac murmur, recognising the signs and symptoms of valvular heart disease.
- Describe the indications for intervention for common valvular pathologies
- Explain the surgical and percutaneous treatment options available for managing valvular disease and define which patients gain benefit from a percutaneous approach
- Implement strategies that ensure continuity of care of patients with valvular heart disease including robust recall systems, effective inter-disciplinary communication and utilisation of referral pathways for timely access to necessary care.
- Presenter(s):Matthew Brooks
- Host:Melbourne Private Hospital
- Activity ID:160116
- QI&CPD Points:3